Editorial: chronic hepatitis B combination therapy-emerging success as proof-of-concept for future hepatitis B eradication?

Aliment Pharmacol Ther. 2018 Jun;47(11):1560-1561. doi: 10.1111/apt.14680.

Authors

Q M Nhu^{1

2

3}, P J Pockros^{2

3}

Affiliations

¹ Department of Medicine, Scripps Clinic - Scripps Green Hospital, La Jolla, CA, USA.
² Scripps Translational Science Institute, The Scripps Research Institute, La Jolla, CA, USA.
³ Division of Gastroenterology & Hepatology, Scripps Clinic - Scripps Green Hospital, La Jolla, CA, USA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antiviral Agents*
Hepatitis B Surface Antigens
Hepatitis B*
Hepatitis B, Chronic*
Humans
Interferons

Substances

Antiviral Agents
Hepatitis B Surface Antigens
Interferons

Grants and funding